Researchers at the University of Queensland’s Australian Institute for Bioengineering and Nanotechnology are working to develop a vaccine in just 100 days to support future pandemic preparedness. The ‘100 Days Mission’ challenge – set by the Coalition for Epidemic Preparedness Innovations (CEPI) – is a real-time test to see how fast science can respond to emerging viral threats.

Led by vaccine development expert Professor Keith Chappell, UQ’s Vaccine Rapid Response team is now 65 days into the challenge of producing the first-ever vaccine for the deadly Bolivian Chapare virus, which causes severe haemorrhagic fever. The most promising candidate will be used to create a clinical grade batch at AIBN’s National Biologics Facility. The work highlights AIBN’s critical role in advancing vaccine technology and strengthening global pandemic preparedness.

Read the full story from the Australian Institute for Bioengineering and Nanotechnology here.